ZCMD Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

03
Price $1.85
P/E -0.2
EPS $-1.85
Revenue $11M
ROE -32.0%
52W Range $1–$967

ZCMD Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

04
range
bars

Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.

Stock splits 4
Ex-date Split Type
June 29, 2026 1-for-3 Reverse
June 8, 2026 1-for-31 Reverse
March 2, 2026 1-for-8 Reverse
Feb. 29, 2024 1-for-10 Reverse

10-Year Performance Revenue, net income, margins and EPS trends

06
Revenue$11M
2017-12-31 → 2025-12-31
EPS$-1.85
2020-12-31 → 2025-12-31
Free Cash Flow·
2019-12-31 → 2019-12-31
Net margin-55.5%
2019-12-31 → 2025-12-31
Valuation & Ratios 07–12

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Metric 5Y trend ZCMD 5Y avg Peer Median Verdict
P/E -0.25Y avg ≈34.7 ≈34.7 · ·

Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.

value · ≈ 5Y avg · industry median · verdict relative to median

Full Fundamentals All metrics by year — income statement, balance sheet, cash flow

15
Income Statement 16
Metric Trend 20252024202320222021202020192018
Revenue $11M$16M$19M$14M$16M$18M$15M$13M
Cost of Revenue $6M$7M$11M$8M$7M$6M$5M$4M
Gross Profit $5M$9M$9M$6M$9M$12M$10M$8M
R&D Expense $8.1K$252.5K$514.4K$411.5K$758.9K$816.6K$864.3K$1M
SG&A Expense $10M$5M$7M$7M$6M$3M$3M$1M
Operating Expenses $11M$9M$22M$9M$10M$7M$7M$5M
Operating Income $-6M$-341.3K$-13M$-3M$-320.7K$4M$4M·
Other Non-op $79.4K$160.0K$1M$262.4K$34.0K$305.6K$534.0K$37.4K
Pretax Income $-6M$61.8K$-12M$-3M$-110.8K$5M$4M$4M
Income Tax $46.2K$335.2K$-669.8K$272.3K$-349.4K$484.8K$387.1K$502.1K
Net Income $-6M$-643.2K$-11M$-3M$238.7K$4M$4M$3M
EPS (Basic) $-1.85$-0.99$-34.83$-1.13$0.10$0.18$0.19·
EPS (Diluted) $-1.85$-0.99$-34.83$-1.13$0.10$0.18··
Shares (Basic) 3,418,290650,678325,4192,599,7762,493,85124,425,637··
Shares (Diluted) 3,418,290650,678325,4192,599,7762,493,85124,425,63721,600,135·
EBITDA $-6M$-110.2K$-13M$-3M$-320.7K···
Balance Sheet 25
Metric Trend 20252024202320222021202020192018
Cash & Equivalents $8M$8M$8M$12M$14M$15M$8M$8M
Short-term Investments $6M$5M$6M$518.4K$296.2K$2M·$1M
Receivables $3M$5M$3M$7M$9M$10M$5M$2M
Inventory ·$586.2K$592.4K$189.1K····
Prepaid Expense $23.8K$81.2K$1M$116.0K·$554.3K$325.5K$562.6K
Other Current Assets $233.0K$273.7K$451.4K$493.0K$375.7K$2M$1M$923.3K
Current Assets $17M$19M$19M$23M$27M$30M$15M$13M
PP&E (Net) $6M$6M$3M$4M$4M$2M$2M$669.9K
PP&E (Gross) ···$4M$4M$2M$304.3K$167.5K
Accum. Depreciation $675.7K$400.6K$196.6K$379.9K$636.2K$313.9K$120.0K$46.1K
Goodwill ···$6M····
Intangibles $7.6K$12.2K$17.5K$912.1K$30.3K$35.0K$37.3K$44.1K
Total Assets $24M$26M$24M$39M$36M$35M$18M$14M
Accounts Payable $526.1K$535.1K$683.9K$140.8K$38.9K$408.4K$117.1K$23.6K
Short-term Debt ·······$727.2K
Current Liabilities $2M$2M$3M$4M$4M$3M$2M$2M
Capital Leases ·$23.8K$571.9K$1M$112.6K·$41.4K·
Deferred Tax $22.3K$179.6K$128.2K$208.2K····
Total Liabilities $2M$2M$3M$6M$4M$3M$2M$3M
Common Stock ···$2.1K$1.9K$1.9K$1.6K·
Paid-in Capital ··$25M$25M$23M$23M$12M$12M
Retained Earnings $-14M$-8M$-7M$4M$7M$7M$3M$-384.3K
AOCI $-1M$-2M$-1M$-511.8K$1M$915.2K$-344.8K$-171.2K
Stockholders' Equity $19M$21M$18M$30M$33M$32M$15M$11M
Liabilities + Equity $24M$26M$24M$39M$36M$35M$18M$14M
Cash Flow 14
Metric Trend 20252024202320222021202020192018
D&A $290.2K$231.1K$518.5K$383.3K$341.6K···
Stock-based Comp $4M$109.7K$135.5K$160.8K$211.8K···
Deferred Tax $-82.5K$287.7K$-739.2K$134.1K$-1M$58.4K$318.1K$-61.0K
Amort. of Intangibles $5.0K$5.0K$335.5K$119.2K$5.5K$4.5K$6.2K$5.1K
Other Non-cash $3M$-1M$11M·····
Operating Cash Flow $845.4K$-1M$54.2K$-661.7K$3M$-1M$1M$1M
CapEx ······$1M$668.1K
Investing Cash Flow $-826.6K$-2M$-4M$-3M$-4M$-4M$-203.1K$-504.0K
Stock Issued ·$4M·$2M·$12M··
Net Stock Activity ·$4M···$12M··
Financing Cash Flow ·$4M·$2M·$11M$-1M$4M
Net Change in Cash $256.8K$292.6K$-4M$-2M$-1M$7M$-86.1K$5M
Taxes Paid $126.6K$45.9K$114.5K$134.2K····
Free Cash Flow ······$95.1K·
Profitability 8
Metric Trend 20252024202320222021202020192018
Gross Margin 45.0%56.2%43.8%44.9%57.9%66.0%68.7%·
Operating Margin -54.4%-2.1%-68.3%-20.9%-2.0%···
Net Margin -55.5%-4.0%-58.3%-19.9%1.5%24.8%27.2%·
Pretax Margin -50.7%0.39%-61.6%-18.0%-0.68%27.5%29.5%·
EBITDA Margin -51.9%-0.69%-65.7%-20.9%-2.0%···
ROA -25.2%-2.6%-36.0%-7.5%0.67%17.0%25.5%·
ROE -32.0%-3.3%-47.3%-9.0%0.74%18.9%30.2%·
ROIC -33.5%7.2%-69.7%-10.9%2.1%···
Liquidity & Solvency 2
Metric Trend 20252024202320222021202020192018
Current Ratio 11.112.27.05.57.69.96.2·
Quick Ratio 10.911.66.04.56.59.25.5·
Efficiency 3
Metric Trend 20252024202320222021202020192018
Asset Turnover 0.50.60.60.40.50.70.9·
Inventory Turnover ·11.828.082.4····
Receivables Turnover 3.04.44.21.81.72.34.2·
Per Share 3
Metric Trend 20252024202320222021202020192018
Revenue / Share $3.33$3.05$7.46$0.54$0.65···
Cash Flow / Share $0.25$-0.28$0.02$-0.03$0.11···
EPS (TTM) $-1.85$-0.99$-34.83$-1.13$0.10$0.18··
Valuation (TTM) 4
Metric Trend 20252024202320222021202020192018
Revenue TTM $11M$16M$19M$14M$16M$18M$15M·
Net Income TTM $-6M$-643.2K$-11M$-3M$238.7K$4M$4M·
P/E -0.2-1.6-0.1-10.2185.492.9··
Earnings Yield -411.1%-61.1%-992.3%-9.8%0.54%1.1%··

Most recent period on the left · null values shown as ·

Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years

16
Metric 2025-12-312024-12-312023-12-312022-12-312021-12-31
Revenue $11M $16M $19M $14M $16M
Gross Margin % 45.0% 56.2% 43.8% 44.9% 57.9%
Operating Margin % -54.4% -2.1% -68.3% -20.9% -2.0%
Net Income $-6M $-643.2K $-11M $-3M $238.7K
Diluted EPS $-1.85 $-0.99 $-34.83 $-1.13 $0.10

Institutional owners (13F)

17
Institutional activity — Q4 2025 vs prior quarter
New positions Exited positions Increased Decreased Net shares change
3 (+2 vs prior Q) 0 (-1 vs prior Q) 1 (0 vs prior Q) 1 (+1 vs prior Q) +38K

Compared to Q3 2025. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.

Activists & 5%+ owners 2 positions

18

Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.

Filer Filed Stake Status Purpose Filing
More Healthy Holdings Limited, Yang Weiguang ×2 filings July 22, 2026 70.10% Amendment · SEC
More Healthy Holdings Limited S.S. or, Weiguang Yang (“ Yang ”) S.S. or ×2 filings May 21, 2021 · Initial filing Passive investment SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Company insiders 1 insider · 1 officers · 1 directors

19
Insider Role Last activity Shares owned Buys 12m Sells 12m Net 12m
Weiguang Yang Chief Executive Officer July 21, 2026 A 206,721 0 0 $0

Insiders from SEC Form 3/4/5 filings; net = open-market P/S only

Peer comparison (GICS sub-industry) Key metrics vs sector peers

22

FY basis, prices as of each company's last fiscal year-end close.

Ticker Market Cap P/E Rev YoY Net Margin ROE Gross Margin
ZCMD · -0.2 · -55.5% -32.0% 45.0%
FEDU $228M 7.5 · 12.1% 6.6% 25.8%
YQ · -11.5 · -145.6% -45.4% 47.8%
EDTK $16M -2.0 · -60136.2% -82.8% 50.5%
NAMI $1.09B -10.9 · -22.8% -87.4% 11.0%
WAFU $5M -6.2 · -17.4% -10.7% 29.1%
LXEH · · · -395.4% -81.5% -38.7%
GSUN · · · -14.3% -101.8% 2.3%
VSA · · · 165435.0% -202.2% 22.0%
JZ · -12.9 · -22.4% -43.8% 17.7%

My Metrics Your personal watchlist — selected rows from Full Fundamentals

26

Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.

Source: SEC 20-F filed Apr 3, 2026